- Recent Funding
- Investors
- Michael Diekmann
Michael Diekmann portfolio
Michael Diekmann has 1 portfolio company on record at Recent Funding.
About this page
It is an angel investor. Its most recent investment on record is Huma Therapeutics's $130M Series B+ round in May 2021, alongside Leaps by Bayer, Samsung Next, HAT Sicaf and 4 others. That company is in AI agents.
What Michael Diekmann invests in
- AI agents · 1 · 100%
- Health and bio · 1 · 100%
- Data and analytics · 1 · 100%
How Michael Diekmann invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $130M |
Michael Diekmann portfolio companies
HHuma Therapeutics$130MSeries B+ · May 2021
| Company | Round with Michael Diekmann | Total raised | Latest raise |
|---|---|---|---|
AI agents |
Series B+ · $130M | $248M | Sep 11, 2024 round |
Most frequent co-investors
SSamsung Next1 shared round · last May 12, 2021
HHitachi Ventures1 shared round · last May 12, 2021
UUnilever Ventures1 shared round · last May 12, 2021
NNikesh Arora1 shared round · last May 12, 2021
LLeaps by Bayer1 shared round · last May 12, 2021
SSony Innovation Fund1 shared round · last May 12, 2021
HHAT Sicaf1 shared round · last May 12, 2021
Similar investors
WWalden Yan3 companies · 1 deal in 12 mo
HHenry Shi8 companies · 2 deals in 12 mo
AAndrej Karpathy9 companies · 4 deals in 12 mo
PPaul Graham12 companies · 3 deals in 12 mo
JJeff Dean14 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (AI agents).
How this is counted
Share is of the 1 round on Recent Funding that name Michael Diekmann. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Michael Diekmann, which is a subset of its real portfolio. API: /api/v1/investors/michael-diekmann (get a free API key). More: the most active VC firms and new venture capital funds.